(Q58035910)

ORCID Public Data File 2021

author name string

Miriam Royo

1

0 references

Wim Van Den Nest

2

0 references

Montserrat del Fresno

3

0 references

Ariadna Frieden

4

0 references

Dror Yahalom

5

0 references

Michael Rosenblatt

6

0 references

Michael Chorev

New perspectives in cell adhesion: RGD and integrins

7

0 references

publication date

October 2001

0 references

published in

Tetrahedron Letters

0 references

volume

42

0 references

issue

42

0 references

page(s)

7387-7391

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Echistatin is a potent inhibitor of bone resorption in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

The pharmacology of the integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the alpha V beta 3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Discovery of an orally active non-peptide fibrinogen receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Backbone Amide Linker (BAL) Strategy for Solid-Phase Synthesis of C-Terminal-Modified and Cyclic Peptides1,2,3

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Solid-Phase Synthesis with Tris(alkoxy)benzyl Backbone Amide Linkage (BAL)[≠]

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Use of Onium Salt-Based Coupling Reagents in Peptide Synthesis1

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Synthesis and biological activity of O-glycosylated morphiceptin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Covalent immobilization of recombinant human alphavbeta3 integrin on a solid support with retention of functionality

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021

Narcotic antagonistic potency of bivalent ligands which contain beta-naltrexamine. Evidence for bridging between proximal recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4039%2801%2901510-6

7 January 2021